Patents by Inventor Bojiang CHEN

Bojiang CHEN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10815231
    Abstract: The present invention discloses [1,2,4]triazolo[1,5-a]pyridine derivatives, as well as the crystalline form thereof. Compounds provided in the present invention have significant inhibitory effects on tumor cells, can be used for the prevention and/or treatment of tumor-related diseases, especially lung cancer, and have wide application prospects.
    Type: Grant
    Filed: August 16, 2016
    Date of Patent: October 27, 2020
    Assignee: WEST CHINA HOSPITAL, SICHUAN UNIVERSITY
    Inventors: Weimin Li, Yang He, Li Zhang, Bojiang Chen, Zhixin Qiu
  • Patent number: 10611771
    Abstract: The present invention discloses pyrazolo[3,4-d]pyrimidine derivatives of formula (I). Compounds provided in the present invention have significant inhibitory effects on tumor cells, can be used for the prevention and/or treatment of tumor-related diseases, especially lung cancer, and have wide application prospects.
    Type: Grant
    Filed: August 16, 2016
    Date of Patent: April 7, 2020
    Assignee: WEST CHINA HOSPITAL, SICHUAN UNIVERSITY
    Inventors: Yang He, Weimin Li, Li Zhang, Bojiang Chen, Zhixin Qiu
  • Publication number: 20190337937
    Abstract: The present invention discloses [1,2,4]triazolo[1,5-a]pyridine derivatives, as well as the crystalline form thereof. Compounds provided in the present invention have significant inhibitory effects on tumor cells, can be used for the prevention and/or treatment of tumor-related diseases, especially lung cancer, and have wide application prospects.
    Type: Application
    Filed: August 16, 2016
    Publication date: November 7, 2019
    Inventors: Weimin LI, Yang HE, Li ZHANG, Bojiang CHEN, Zhixin QIU
  • Publication number: 20190263822
    Abstract: The present invention discloses pyrazolo[3,4-d]pyrimidine derivatives of formula (I). Compounds provided in the present invention have significant inhibitory effects on tumor cells, can be used for the prevention and/or treatment of tumor-related diseases, especially lung cancer, and have wide application prospects.
    Type: Application
    Filed: August 16, 2016
    Publication date: August 29, 2019
    Inventors: Yang HE, Weimin LI, Li ZHANG, Bojiang CHEN, Zhixin QIU